Yakult Honsha Co Ltd (2267):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yakult Honsha Co Ltd (2267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9938
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yakult Honsha Co Ltd (Yakult) is a probiotics company that undertakes the development, manufacture and commercialization of probiotic and pharmaceutical products. The company’s product portfolio encompasses food and beverages such as fermented milk drinks, juice and others products; pharmaceuticals; and cosmetics. Its pharmaceuticals consist of prescription and non-prescription drugs, quasi drugs, and medical devices. Yakult develops and commercializes drugs in the field of oncology. The company provides cosmetics with moisturizing agents to protect the health of the skin, body and mind. It makes its products available through supermarkets, convenience stores and home delivery. Yakult is headquartered in Minato-ku, Tokyo, Japan.

Yakult Honsha Co Ltd (2267) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sanofi Enters into Co-Promotion Agreement with Yakult Honsha 10
Licensing Agreements 11
Yakult Honsha Enters into Licensing Agreement with Verastem 11
Yakult Honsha Enters into Licensing Agreement with Nissan Chemical 12
Yakult Honsha Co Ltd – Key Competitors 13
Yakult Honsha Co Ltd – Key Employees 14
Yakult Honsha Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 18
Strategy And Business Planning 18
May 29, 2018: Yakult Establishes Branch in Guiyang, Guizhou Province, China 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yakult Honsha Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sanofi Enters into Co-Promotion Agreement with Yakult Honsha 10
Yakult Honsha Enters into Licensing Agreement with Verastem 11
Yakult Honsha Enters into Licensing Agreement with Nissan Chemical 12
Yakult Honsha Co Ltd, Key Competitors 13
Yakult Honsha Co Ltd, Key Employees 14
Yakult Honsha Co Ltd, Other Locations 15
Yakult Honsha Co Ltd, Subsidiaries 16

List of Figures
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yakult Honsha Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Yakult Honsha Co Ltd (2267):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Lincoln Electric System:企業の発電所・SWOT分析2018
    Lincoln Electric System - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Rehrig Pacific Company:企業の戦略的SWOT分析
    Rehrig Pacific Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Pricer AB (PRIC B):企業の財務・戦略的SWOT分析
    Pricer AB (PRIC B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PDL BioPharma Inc (PDLI)-製薬・医療分野:企業M&A・提携分析
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Arabian Shield Cooperative Insurance Company:企業の戦略・SWOT・財務情報
    Arabian Shield Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Arabian Shield Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Kelly Services, Inc.:企業の戦略・SWOT・財務情報
    Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ARC Document Solutions Inc (ARC):企業の財務・戦略的SWOT分析
    Summary ARC Document Solutions Inc (ARC), formerly American Reprographics Company is a provider of technology and document solutions. The company’s services comprise onsite managed print services, construction document and information management, archiving and information management, and sale of web …
  • Bajaj Allianz Life Insurance Company Ltd:企業の戦略・SWOT・財務分析
    Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • PhoenixBio Co Ltd (6190):製薬・医療:M&Aディール及び事業提携情報
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blo …
  • CAS Medical Systems Inc (CASM):企業の財務・戦略的SWOT分析
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Partner Reinsurance Asia Pte. Ltd.
    Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Ambry Genetics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secur …
  • Martin Midstream Partners LP (MMLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Martin Midstream Partners LP (Martin Midstream) is a midstream service provider that carries out the transportation, storage and distribution of petroleum products and by-products. Its service offerings include terminalling, transportation, distribution, and midstream logistical services, be …
  • Analog Modules, Inc.:企業の戦略・SWOT・財務情報
    Analog Modules, Inc. - Strategy, SWOT and Corporate Finance Report Summary Analog Modules, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ASUSTeK Computer Inc.:企業の戦略・SWOT・財務情報
    ASUSTeK Computer Inc. - Strategy, SWOT and Corporate Finance Report Summary ASUSTeK Computer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nexstim Plc (NXTMH)-医療機器分野:企業M&A・提携分析
    Summary Nexstim Plc (Nexstim) is a medical technology company, which focuses on navigated brain stimulation (NBS) to improve rehabilitation in stroke patients non-invasively . Its NBS system, which is FDA cleared and CE-marked, applies navigated transcranial magnetic stimulation (nTMS) device for pr …
  • IMV Inc (IMV):製薬・医療:M&Aディール及び事業提携情報
    Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a clinical-stage biopharmaceutical company that develops cancer immunotherapies and infectious disease vaccines. The company’s product candidates include DPX-Survivac, a T cell activating immunotherapy that identifies and disrupts cancer biology …
  • Globavir Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Globavir Biosciences Inc (Globavir) is a specialty biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. Through Globavir’s Drug Discovery Platform (GDDP), it generates a wide range of small molecule c …
  • Rebiotix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that offers treatment solutions for debilitating diseases by harnessing the power of the human microbiome. The company harnesses microbiota restoration therapy, a drug delivery platform that releases hea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆